HOME >> BIOLOGY >> NEWS
Miniature spectrometer can detect biological hazards

OAK RIDGE, Tenn., March 17, 2003 Researchers at the Department of Energy's Oak Ridge National Laboratory have developed a miniature device that can identify as little as a fraction of a spore of anthrax and other biological hazards within 30 milliseconds.

The Calorimetric Spectrometer (CalSpec TM) device technology can accurately identify biological hazards such as anthrax almost instantly. The device can operate with only a fraction of a spore while isolating the DNA/RNA photothermal signature that allows for detection, identification and measurement of a substance.

Such prompt detection and identification of hazardous materials could greatly enhance the protection of first-responder emergency personnel and the capabilities of early warning systems. Current technologies do not provide the level of sensitivity offered by the CalSpec TM chemical, biological and DNA/RNA detection system.

Researchers Panos Datskos and Slobodan Rajiic of ORNL's Engineering Science and Technology Division developed the CalSpec TM technology. ORNL has licensed the technology exclusively to Innovative American Technology of Herndon, Va., and Boca Raton, Fla.

The CalSpec TM can detect hazards by identifying their molecules. The molecular absorption can induce stress changes that allow for an initial detection that can be used for measurement. The identification of chemical and/or biological molecules, along with DNA/RNA, creates a photothermal signature.

The spectrometer could have a wide variety of applications in commercial industry and in homeland defense, including mass transit and airport security; in the postal industry, to protect workers and the public; and in monitoring air quality systems.

"The CalSpec TM detection device could provide a cost-effective and easily deployed upgrade for these systems to enable rapid detection, greater accuracy and most important increased sensitivity down to a fraction of a spore," said Jack Cumming
'"/>


17-Mar-2003


Page: 1 2

Related biology news :

1. Miniature biolab embedded on silicon chip
2. Miniature implantable sensor likely lifesaver for patients
3. Scientists Excited About Miniature Cooking Pots
4. Collaboration at EMSL produces innovative mass spectrometer
5. Mass spectrometer weighs in as proteomics breakthrough
6. The worlds most powerful NMR spectrometer
7. New sequence involved in DNA replication timing may aid in cancer detection
8. Scientists find nanowires capable of detecting individual viruses
9. Brain has center for detecting sound motion
10. Early detection hope for eye disease
11. Wrapping a memory with an experience, capacity for recollection detected in non-human species

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Miniature spectrometer can detect biological hazards

(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... the next step in its expanded strategy to rebuild ... the naming of current Chief Operating Officer, Valerie ... current Chairman of the Board and CEO James ... changes are effective January 1, 2015. "Jim ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
(Date:12/15/2014)... TIKVAH, Israel , Dec. 15, 2014 ... ), a leading developer of adult stem cell technologies ... Cell Therapeutics Ltd. was awarded a grant of approximately ... of the Chief Scientist (OCS).  This is the eighth ... support from the Office of the Chief Scientist, which ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: